Thalidomide shows efficacy as adjuvant therapy for hepatocellular carcinoma patients
Saturday, April 2, 2011 - 04:00
in Health & Medicine
Thalidomide has shown potential to be used as the first adjuvant therapy for hepatocellular carcinoma (HCC), according to data presented at the International Liver Congress 2011.1